NCT07387926 2026-02-04Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)NovartisPhase 1/2 Not yet recruiting50 enrolled